Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04726332 |
| Title | Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Exelixis |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Exelixis Clinical Site #4 | Atlanta | Georgia | 30322 | United States | Details | |
| Exelixis Clinical Site #3 | Boston | Massachusetts | 02215 | United States | Details | |
| Exelixis Clinical Site #2 | Dallas | Texas | 75230 | United States | Details | |
| Exelixis Clinical Site #5 | Houston | Texas | 77030 | United States | Details | |
| Exelixis Clinical Site #1 | San Antonio | Texas | 78229 | United States | Details |